Deep Tech Startups

Encapsys specializes in microencapsulation technology to create advanced products for partners across multiple industries, from consumer goods to agrochemicals. The company leverages over 60 years of expertise and 115+ patents to deliver encapsulated materials that improve product performance while reducing material waste and environmental impact.

1 investor

EncepHeal develops small-molecule medications to treat substance use disorders, with a lead therapeutic targeting stimulant addiction such as cocaine and methamphetamine. Its compounds act as atypical/allosteric modulators of the dopamine transporter, developed with partners at the NIH and Wake Forest.

1 investor

EnCoat is a research and technology organisation developing antifouling coating solutions aimed at improving efficiency, environmental sustainability, and cost-effectiveness for the maritime and coating industry. Part of the Scanventure group, it works to translate university research into industry-ready products, including reducing copper use in antifouling coatings.

1 investor

Endeavour Aerospace is an Australian company developing dual-use aerospace technology, including solid rocket motors, propulsion, avionics, and guidance and control systems. It also operates the Red Sands Launch Range in the Australian Outback, with rocket motor products planned for 2027.

1 investor

Endlyz develops small-molecule disease-modifying therapeutics targeting the ATP13A2 and ATP10B lysosomal transporters to restore endo-lysosomal function and counter neurodegeneration. Its initial focus is genetic subsets of Parkinson's disease, with plans to expand into sporadic Parkinson's and other dementias.

1 investor

Endurion builds mission-critical systems for national security and defense operations in the United States, combining operational expertise with AI-enabled analytics and technology platforms. The company serves defense and security missions where reliability under pressure is required.

1 investor

ENERCON is an engineering and environmental support services firm that assists clients with the safe and efficient production, delivery, and use of energy through design, regulatory services, environmental protection, and compliance work.

1 investor

EnerVenue manufactures long-duration energy storage systems for grid-scale applications, using iron-based chemistry to achieve 30-year operational life with minimal degradation. The company serves energy developers, integrators, and data center operators seeking cost-effective, turnkey energy storage solutions without thermal management or fire suppression requirements.

1 investor

Engidi builds ACRUX, an IoT wearable device that connects to workers and provides real-time data on their location and health to help companies monitor and reduce safety risks in industrial settings. It serves industries such as petrochemicals, electricity, mining, road maintenance, civil works, and rescue teams.

1 investor

Engimmune develops soluble TCR therapeutic candidates using AI-guided innovation and protein engineering for oncology and immunotherapy applications. The company was founded by veteran biotherapeutics developers and focuses on unlocking therapeutic potential through its differentiated technology platform.

1 investor

Engram Biosciences is an applied neurobiology research lab that builds tools and models to aggregate human brain data at scale, operating a 10,000 sq ft automated lab. It is a research-driven company staffed by researchers and engineers working in neuroscience and biotechnology.

1 investor

Engramme builds "Large Memory Models," novel AI models of human memory intended to give people searchless, promptless recall of the people, conversations, and places they have encountered. The company is developing a consumer-facing beta product.

1 investor

Enhanced Drilling produces EC-Monitor, a real-time well monitoring system that tracks volume fluctuations and detects anomalies in drilling operations. The system is designed for offshore and deepwater drilling environments where precise pressure and kick/loss detection are critical for safety.

1 investor

Enjamb develops an agentic AI platform for biopharma R&D teams that automates drug discovery, trial execution, and regulatory filings. The platform integrates with existing systems to support programs from early discovery through FDA approval.

1 investor

Ennoventure provides covert, cryptographic authentication signals embedded invisibly into product packaging artwork using standard printing equipment and conventional inks, verifiable via any smartphone. It serves brands for anti-counterfeiting and brand protection, offering AI-based verification, market intelligence analytics, and integration through APIs and SDKs.

1 investor

Enodia Therapeutics develops small-molecule therapies that target protein degradation at the point of synthesis using a machine learning-enabled platform. The company serves the therapeutic development market with its targeted protein degradation approach.

1 investor

ENS Dynamics develops autonomous UAV interceptor technology to neutralize aerial drone threats and protect infrastructure. Founded in 2024 and based in Switzerland, the company produces the WASP Interceptor System for airspace security applications.

1 investor

Ensem Therapeutics is a drug discovery and development company focused on oncology therapeutics, leveraging proprietary computational chemistry and protein structural dynamics platforms. The company advances small molecule and targeted therapies from discovery through clinical development.

1 investor

Ensoul is building AI tools aimed at accelerating robotics research, targeting robotics researchers as its customers. The company is run by a team of AI scientists and roboticists.

1 investor

Entact is a drug discovery company developing treatments for patients. It works in the biotechnology and therapeutics sector.

1 investor

Enthought provides scientific computing services, enterprise scientific software development, and digital transformation for science, applying Python, AI/machine learning, and simulation to research and R&D problems. It serves organizations in sectors such as pharmaceuticals, materials, and semiconductors, with operations in the U.S. and Japan.

1 investor

Entropic Communications, LLC holds a patent portfolio covering foundational technology for the satellite and cable television industries, including signal delivery, in-home distribution, and home networking. The company licenses these patents, which encompass technologies such as Full Band Capture, Satellite Digital Channel Stacking, and Multimedia over Coax Alliance (MoCA) standards.

1 investor

Countable Labs (formerly Enumerix) develops a digital PCR platform that performs genetic analysis with higher sensitivity, precision, and dynamic range than legacy PCR methods. The technology serves oncology, NIPT (non-invasive prenatal testing), infectious disease, and cell and gene therapy applications.

1 investor

Enuvio manufactures microfluidic devices for cell co-culture and compartmentalization research, including neuronal co-culture, axon guidance, and chemotaxis platforms for life sciences researchers.

1 investor